Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: A prospective cohort of Shinken Database 2007

Hypertension Research

Volumn 32, Issue 10, 2009, Pages 920-926

  Nakamura, Michinari ^a   Yamashita, Takeshi ^a   Yajima, Junji ^a   Oikawa, Yuji ^a   Ogasawara, Ken ^a   Kirigaya, Hajime ^a   Sagara, Koichi ^a   Koike, Akira ^a   Sawada, Hitoshi ^a   Aizawa, Tadanori ^a  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICORANDIL; TICLOPIDINE;

ADULT; AGED; ARTICLE; BLOOD EXAMINATION; CAUSAL ATTRIBUTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA BASE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; JAPANESE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL TIME;

AGED; ANTIHYPERTENSIVE AGENTS; COHORT STUDIES; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; JAPAN; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL; TREATMENT OUTCOME;

EID: 70349996476     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.114     Document Type: Article

References (37)

1. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, Nakamura H, Okubo K, Iida M. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama study. Stroke 2003; 34: 2349-2354.
2. Tonelli M, Jose P, Curhan G, Sacks F, Braunwald E, Pfeffer M, Cholesterol and Recurrent Events (CARE) Trial Investigators. Proteinuria, impaired kidney function, and adverse outcomes in people with coronary disease: Analysis of a previously conducted randomised trial. Br Med J 2006; 332: 1426.
3. Wison S, Foo K, Cunningham J, Cooper J, Deaner A, Knight C, Ranjadayalan K, Timmis AD. Renal function and risk stratification in acute coronary syndromes. Am J Cardiol 2003; 91: 1051-1054.
4. Reinecke H, Trey T, Matzkies F, Fobker M, Breithardt G, Schaefer RM. Grade of chronic renal failure, and acute and long-term outcome after percutaneous coronary interventions. Kidney Int 2003; 63: 696-701.
5. Inaguma D, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Inaba S, Kurata K, Yuzawa Y, Matsuo S. Relationship between renal function at the time of percutaneous coronary intervention and prognosis in ischemic heart disease patients. Clin Exp Nephrol 2007; 11: 56-60.
6. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW, American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003; 108: 2154-2169.
7. Iseki K, Horio M, Imai E, Matsuo S, Yamagata K. Geographic difference in the prevalence of chronic kidney disease among Japanese screened subjects: Ibaraki versus Okinawa. Clin Exp Nephrol 2009; 13: 44-49.
8. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
9. Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol 2007; 11: 156-163.
10. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Ohnishi H, Saitoh S, Sakata K, Okayama A, Ueshima H, The NIPPON DATA90 Research Group. Chronic kidney disease is a risk factor for cardiovascular death in a community-based population in Japan: NIPPON DATA90. Circ J 2006; 70: 954-959.
11. Ninomiya T, Kiyohara Y, Tokuda Y, Doi Y, Arima H, Harada A, Ohashi Y, Ueshima H, Japan Arteriosclerosis Longitudinal Study Group. Impact of kidney disease and blood pressure on the development of cardiovascular disease: An overview from the Japan Arteriosclerosis Longitudinal Study. Circulation 2008; 118: 2694-2701.
12. Shiba N, Matsuki M, Takahashi J, Tada T, Watanabe J, Shimokawa H. Prognostic importance of chronic kidney disease in Japanese patients with chronic heart failure. Circ J 2008; 72: 173-178.
13. Iseki K, Tohyama K, Matsumoto T, Nakamura H. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 2008; 31: 249-255.
14. Suzuki S, Yamashita T, Ohtsuka T, Sagara K, Uejima T, Oikawa Y, Yajima J, Koike A, Nagashima K, Kirigaya H, Ogasawara K, Sawada H, Aizawa T. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008; 72 914-920.
15. Japanese Society of Nephrology & The Japanese Society of Hypertension. CKD Practical Guide (Hypertension). Tokyoigakusha, 2008, pp 20. (Japanese).
16. Matsuo S, Imai E, Horio Y, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A, On behalf of the collaboraters for developing Japanese equation for estimating GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
17. National Kidney Foundation. Kidney Disease Outcome Quality Initiative (K/ DOQI) clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(suppl 1): S1-S266.
18. Japanese Society of Nephrology. Evidence-Based Practice Guideline for the Treatment of CKD 2009. Tokyoigakusha, 2009, p17 (Japanese).
19. Wen CP, Cheng TY, Tsai MK, Chang YC, Chan HT, Tsai SP, Chiang PH, Hsu CC, Sung PK, Hsu YH, Wen SF. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008; 371: 2173-2182.
20. Iseki K, Kohagura K, Sakima A, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res 2007; 30: 55-62.
21. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
22. Weiner DE, Tighiouart H, Stark PC, Amin MG, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 2004; 44: 198-206.
23. Cardarelli F, Bellasi A, Veledar E, Vaccarino V, Raggi P. Impact of race and chronic kidney disease on 1-year outcome in patients undergoing percutaneous coronary interventions: A single tertiary center experience. Am Heart J 2008; 155: 1027-1032.
24. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA, Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators. Survival after coronary revascularization among patients with kidney disease. Circulation 2004; 110: 1890-1895.
25. Fathi RB, Gurm HS, Chew DP, Gupta R, Bhatt DL, Ellis SG. The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention. Am Heart J 2005; 150: 1190-1197.
26. Bonello L, De Labriolle A, Roy P, Steinberg DH, Okabe T, Pinto Slottow TL, Xue Z, Torguson R, Suddath WO, Satler LF, Kent KM, Pichard AD, Lindsay J, Waksman R. Impact of optimal medical therapy and revascularization on outcome of patients with chronic kidney disease and on dialysis who presented with acute coronary syndrome. Am J Cardiol 2008; 102: 535-540.
27. Blackman DJ, Pinto R, Ross JR, Seidelin PH, Ing D, Jackevicius C, Mackie K, Chan C, Dzavik V. Impact of renal insufficiency on outcome after contemporary percutaneous coronary intervention. Am Heart J 2006; 151: 146-152.
28. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17.
29. Arici M, Walls J. End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 2001; 59: 407-414.
30. Jungers P, Massy ZA, Nguyen Khoa T, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha B, Man NK. Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant 1997; 12: 2597-2602.
31. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002; 106: 2207-2211.
32. Japanese Society of Dialysis Therapy. An overview of regular dialysis treatment in Japan as of Dec 31, 2006. 2007. http://docs.jsdt.or.jp/ overview/ (accessed 25 February 2009).
33. Chen MS, John JM, Chew DP, Lee DS, Ellis SG, Bhatt DL. Bare metal stent restenosis is not a benign clinical entity. Am Heart J 2006; 151: 1260-1264.
34. Papafaklis MI, Naka KK, Papamichael ND, Kolios G, Sioros L, Sclerou V, Katsouras CS, Michalis LK. The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention. Catheter Cardiovasc Interv 2007; 69: 189-197.
35. Mishkel GJ, Varghese JJ, Moore AL, Aguirre F, Markwell SJ, Shelton M. Short- and long-term clinical outcomes of coronary drug-eluting stent recipients presenting with chronic renal disease. J Invasive Cardiol 2007; 19: 331-337.
36. Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Makino H, Hishida A, Matsuo S. Slower decline of glomerular filtration rate in the Japanese general population: A longitudinal 10-year follow-up study. Hypertens Res 2008; 31: 433-441.
37. Iseki K, Iseki C, Ikemiya Y, Kinjo K, Takishita S. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan. Hypertens Res 2007; 30: 167-174.